RxDoctor Payments Data

Nathan Roberts, MD

Family Medicine · Tuscola, ILNPI 1225089626

Payments from drug & device makers

$539in general payments, 2019–2025

Across 28 payments — averaging $19.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$183
  • Lilly USA, LLC$104
  • Coloplast$68
  • AstraZeneca$52
  • Amgen$42
  • Merck$24
  • plus $66 from 4 others

What the payments were for

  • Food & beverage$539100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$539 in reported general payments places this provider in the 65th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$118,316
Medicare patients
328
Services billed
3,502

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin73$79,217
EliquisApixaban66$73,141
OzempicSemaglutide58$69,671
XareltoRivaroxaban43$47,015
TrulicityDulaglutide16$32,992
JanuviaSitagliptin Phosphate21$28,782
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$22,844
FarxigaDapagliflozin Propanediol30$20,729
LinzessLinaclotide25$18,289
Repatha SureclickEvolocumab20$17,618
MounjaroTirzepatide12$12,720
Tresiba Flextouch U-100Insulin Degludec16$10,039
Breo ElliptaFluticasone/Vilanterol24$10,018
JanumetSitagliptin Phos/Metformin Hcl12$6,854
DuleraMometasone/Formoterol13$5,982

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$183$69,67158 claims
Lilly USA, LLCTrulicity, Mounjaro$104$45,71228 claims
MerckJanuvia, Janumet, Dulera$24$41,61846 claims
AstraZenecaFarxiga$52$20,72930 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Tuscola

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →